more News from Cannabis world:
Cannabis Science CEO Sees Over 3,000 Shareholders Registering for Their Loyalty Gifts, as the Company Looks at Plans Coming Together to Unveil the Schematics of Its 360,000 sq. ft. Nevada Drug Development Complex Within the Next Few Days
COLORADO SPRINGS, CO--(Marketwired - May 3, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, is currently processing more than 3,000 shareholder requests for their "loyalty gift" from CEO Raymond C. Dabney. This is a remarkable number to say the least, as the company draws near the release of the schematics for its 360,000 sq. ft., Nevada drug development complex later this week.
